Xiaona Mao - Concepedia

Author

Xiaona Mao

First Affiliated Hospital of Xi'an Jiaotong University

Also Known As

XIAONA MAO, Xiao-Na Mao, Xiaona Mao

Publications

709

Citations

H-Index

Concepts

All Affiliations

First Affiliated Hospital of Xi'an Jiaotong University Sichuan University Ningbo No. 2 Hospital Huashan Hospital Sichuan Academy of Traditional Chinese Medicine

About

Xiaona Mao is an author at First Affiliated Hospital of Xi'an Jiaotong University specializing in medicine, immunology, and hepatology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	331
2	Immunology	3	3	238
3	Cell Biology	2	2	71
4	Hepatology	2	2	211
5	Cellular Physiology	1	1	47

Xiaona Mao

Publications

674

Citations

H-Index

Page 1

	Year	Citations
Relationship between serum HBV-RNA levels and intrahepatic viral as well as histologic activity markers in entecavir-treated patients Jing Wang, Yiqi Yu, Guojun Li, Journal of Hepatology Diagnostic VirologyViral PersistenceHepatologyViral HepatitisEntecavir-treated Patients	2017	138
Suppression of tumor angiogenesis by metformin treatment<i>via</i>a mechanism linked to targeting of HER2/HIF-1α/VEGF secretion axis Jichang Wang, Guangyue Li, Yaochun Wang, Oncotarget	2015	106
Discovering Potent Small Molecule Inhibitors of Cyclophilin A Using de Novo Drug Design Approach Shuaishuai Ni, Yaxia Yuan, Jin Huang, Journal of Medicinal Chemistry	2009	93
Loss of LKB1 disrupts breast epithelial cell polarity and promotes breast cancer metastasis and invasion Juan Li, Jie Liu, Pingping Li, Journal of Experimental & Clinical Cancer Research	2014	85
Sequential Combination Therapy with Pegylated Interferon Leads to Loss of Hepatitis B Surface Antigen and Hepatitis B e Antigen (HBeAg) Seroconversion in HBeAg-Positive Chronic Hepatitis B Patients Receiving Long-Term Entecavir Treatment Guojun Li, Yiqi Yu, Shao‐Long Chen, Antimicrobial Agents and Chemotherapy Long-term Entecavir TreatmentHbsag LossImmunodeficienciesImmunologyHepatitis B	2015	73
Protective Effect of Klotho against Ischemic Brain Injury Is Associated with Inhibition of RIG-I/NF-κB Signaling Hongjing Zhou, Hui Li, Meng-Qi Shi, Frontiers in Pharmacology	2018	59
CRB3 regulates contact inhibition by activating the Hippo pathway in mammary epithelial cells Xiaona Mao, Pingping Li, Yaochun Wang, Cell Death and Disease Hippo PathwayHippo SignallingSignal TransductionSignaling PathwayCell Regulation	2017	47
Neuroprotective effect of a novel gastrodin derivative against ischemic brain injury: involvement of peroxiredoxin and TLR4 signaling inhibition Xiaona Mao, Hongjing Zhou, Xiaojia Yang, Oncotarget ImmunologyCell DeathPharmacotherapyNeuroprotective EffectOxidative Stress	2017	27
Cell polarity protein CRB3 is an independent favorable prognostic factor for clear cell renal cell carcinoma Xiaona Mao, Pingping Li, Yu Ren, International Journal of Oncology Renal PathologyNegative Crb3 ExpressionCancer BiologyTumor BiologyCell Regulation	2014	24
Pharmacological characterization of a novel gastrodin derivative as a potential anti-migraine agent Ping-Han Wang, Li-Xue Zhao, Jingyu Wan, Fitoterapia Pharmacological CharacterizationMedicinePharmacological AgentNovel Gastrodin DerivativeExperimental Pharmacology	2015	22

Page 1